Related Experiment Video
Updated: Dec 21, 2025

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
Published on: March 17, 2023
Target-responsive vasoactive probes for ultrasensitive molecular imaging.
Robert Ohlendorf1, Agata Wiśniowska2, Mitul Desai1
1Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave. Rm. 16-561, Cambridge, MA, 02139, USA.
Researchers developed novel molecular imaging probes that detect low concentrations of analytes in deep tissue. These probes offer a non-radioactive, non-heavy metal alternative for sensitive molecular detection in living subjects.
Area of Science:
- Biomedical Imaging
- Molecular Probes
- Biomarker Discovery
Background:
- Noninvasive molecular monitoring is crucial for understanding health and disease but faces sensitivity and selectivity challenges.
- Current molecular imaging agents often rely on radiation or heavy metals, limiting their application.
- Developing new probes for deep tissue molecular detection is essential.
Purpose of the Study:
- To create a new class of potent, non-radioactive molecular imaging probes.
- To enable sensitive, volumetric detection of nanomolar-scale analytes in deep tissues.
- To demonstrate the versatility of these probes for detecting biologically relevant molecules.
Main Methods:
- Designed reversibly caged vasodilators activated by specific molecules of interest.
- Combined vasoactive peptides with synthetic chemical appendages and protein blocking domains.
- Utilized functional magnetic resonance imaging (fMRI) for wide-field mapping in rat brains.
Main Results:
- Developed ultrasensitive biotin-responsive imaging agents.
- Successfully mapped biotin targets in rat brains using fMRI.
- Adapted the sensor design for detecting the neurotransmitter dopamine.
Conclusions:
- The novel imaging probes offer a sensitive and selective platform for molecular detection in vivo.
- This approach provides a non-radioactive, non-heavy metal alternative to traditional molecular imaging.
- The technology is versatile and applicable to a range of biologically important molecules.
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
10:46In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment
Published on: March 16, 2018